An alpha level was set at 0.05, and all data were analyzed using SPSS (Version 20.0 Chicago, IL, USA). Ninety-five percent confidence intervals were constructed around the mean change scores. When the 95% confidence interval included zero, the score was not deemed statistically significant. PLX4032 mw A Kruskal-Wallace one-way analysis of variance was used to interpret

all survey data. Results There were no significant group x time interactions (p > 0.05) for body composition, LPM, BPM, WPP, WMP, or VJ, and no effects for treatment. There was a significant effect for time for FM (p = 0.05; ηp 2 = 0.196), LBM (p = 0.001; ηp 2 = 0.551), and %BF (p = 0.008, ηp 2 = 0.335). Mean difference values (±95% CI) depict the significant increase in LBM for both groups (Figure 1). Figure Selleck Tozasertib 1 Body composition measures. Change in body composition measures from baseline values. Lean Mass was significantly increased for PLC and SUP from baseline to final testing. There were no significant changes for Fat Mass. *indicates a significant time effect (p ≥ 0.05). There was a significant time effect for WPP (p = 0.001; ηp 2 = 0.550), BPM (p = 0.001; ηp 2 = 0.448), and LPM (p = 0.001; ηp 2 = 0.632); with no group x time effect for VJ (p = 0.451), or WMP (p = 0.563). Mean difference scores (±95% CI) depict significant increases in BPM, LPM, and WPP, with no differences between groups (Figures 2 and 3). However, SUP group had an increase in leg

press max that was two times greater than that of the PLC group. There was no significant difference between groups for total calories (p = 0.296), grams of fat (p = 0.880), grams of protein (p = 0.884), or grams of carbohydrate consumed (p = 0.170). See Table 2 for nutritional intake data. The most often selleckchem reported side-effects after supplementation were feeling faint, feeling light-headed, dizziness, headache, and nausea. These side-effects were reported by participants in both groups and therefore may or may not be attributable to the supplement. Figure 2 Bench

press and leg press 1RM. Changes in BPMax and LPMax were significant for both groups from baseline testing to final testing. There was no group x time interaction. *indicates significant changes from baseline (p ≥ 0.05). Figure 3 Wingate measures medroxyprogesterone of power. Changes in WMP were not significantly different from baseline testing. WPP changes were significant for both PLC and SUP from baseline to T2 testing. There was no group x time interaction. *indicates significant changes over time (p ≥ 0.05). Table 2 Macronutrient and caloric intake by group   SUP PLC Total Calories 2320.71 ± 664.44 2352.75 ± 570.37 CHO (grams) 259.92 ± 87.25 271.90 ± 66.58 Fat (grams) 91.02 ± 30.01 99.95 ± 40.39 Protein (grams) 105.78 ± 28.45 108.05 ± 31.42 Macronutrient and Calorie information presented as mean ± SD. Food intake was recorded daily throughout the study. There was no significant difference between groups in nutritional intake.